Switching between ticagrelor and clopidogrel in patients who underwent percutaneous coronary intervention: insight into contemporary practice in Chinese patients-Reference-Cited by-同舟云学术

Switching between ticagrelor and clopidogrel in patients who underwent percutaneous coronary intervention: insight into contemporary practice in Chinese patients

Published:2016-05 Issue:suppl F Volume:18 Page:F19-F26
ISSN:1520-765X
Container-title:European Heart Journal Supplements
language:en
Short-container-title:Eur Heart J Suppl

Author:

Wang Xuyun,Xi Shaozhi,Liu Jia,Qin Liuan,Jing Jing,Yin Tong,Chen Yundai

Funder

Beijing Natural Science Foundation of China

National Natural Science Foundation of China

Clinical Research Supportive Fund General Hospital of Chinese People's Liberation Army

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/eurheartjsupp/article-pdf/18/suppl_F/F19/6722074/suw034.pdf

Reference21 articles.

1. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)

2. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation

3. 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction

4. 2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction

5. Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Effect of Platelet Activity, ABCB1 Genetic Polymorphism, and Renal Function on the Development of Ticagrelor-Related Dyspnea in Patients with Acute Coronary Syndrome;Drug Design, Development and Therapy;2024-01

2. Efficacy and Safety Profile of Ticagrelor Versus Clopidogrel in Percutaneous Coronary Intervention (PCI) for Acute Coronary Syndrome (ACS): A Systematic Review and Meta-Analysis;Cureus;2023-10-04

3. Effectiveness of dual antiplatelet de-escalation therapy on the prognosis of patients with ST segment elevation myocardial infarction undergoing percutaneous coronary intervention;BMC Cardiovascular Disorders;2023-03-29

4. De-escalation of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome: An Updated Meta-analysis and Trial Sequential Analysis of 21 Studies and 38,741 Patients;Journal of Cardiovascular Pharmacology;2022-06

5. Mechanistic insights into the CYP2C19 genetic variants prevalent in the Indian population;Gene;2021-06